Multinutrient supplementation and food-related behavioral activation therapy did not reduce episodes of major depressive disorder in overweight or obese adults with subclinical depressive symptoms.
Researchers analyzed pregnant women in the BASIC cohort to determine whether certain lifestyle and background characteristics are linked to an increased risk of developing depression at a specific stage of the perinatal period.
Patients with depressive symptoms, however mild, face increased mortality risk long after an acute myocardial infarction.
Participants who reported chronic headaches were found likely to develop migraines.
The association between chronic and disabling hip pain, and obesity and depression was examined.
Early adherence is an especially problematic, significant and modifiable barrier to quality care for depression.
Researchers examined whether the risk of relapse or time to relapse was related to type of anxiety disorder, duration of previous treatment, and other factors.
Scores for both anxiety and depression are associated with low BMD.
In young adults, MDD, GAD, and SSRI use is associated with bone metabolism.
Elevated cytokine levels could help to identify children who are unlikely to respond to treatment with fluoxetine.
